ES2182546T3 - Imidazo(1,2a)azinas sustituidas como inhibidores selectivos de la cox-2. - Google Patents

Imidazo(1,2a)azinas sustituidas como inhibidores selectivos de la cox-2.

Info

Publication number
ES2182546T3
ES2182546T3 ES99931266T ES99931266T ES2182546T3 ES 2182546 T3 ES2182546 T3 ES 2182546T3 ES 99931266 T ES99931266 T ES 99931266T ES 99931266 T ES99931266 T ES 99931266T ES 2182546 T3 ES2182546 T3 ES 2182546T3
Authority
ES
Spain
Prior art keywords
imidazo
substituted
azins
cox
selective inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99931266T
Other languages
English (en)
Inventor
Gallemi Carles Farrerons
Bono Ignacio-Jose Miquel
Serrat Ana Maria Fernandez
Vidal Carlos Monserrat
Arnal Carmen Lagunas
Guasch Ferran Gimenez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Salvat SA
Original Assignee
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Salvat SA filed Critical Laboratorios Salvat SA
Application granted granted Critical
Publication of ES2182546T3 publication Critical patent/ES2182546T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Una imidazo[1, 2a]azina sustituida de fórmula (I), o un solvato o sal por adición de ácidos farmacéuticamente aceptable de la misma, en la que A y B se seleccionan independientemente entre N y CH, con la condición de que cuando A es N, entonces B es N también; R1 se selecciona entre el grupo que consiste en CH3 y NH2; R2 y R3 se seleccionan entre el grupo que consiste en H, CH3, Cl, Br, COCH3 y OCH3; y R4, R5 y R6 se seleccionan cada uno independientemente entre el grupo que consiste en H, F, Cl, Br, alquilo (C1-C3), trifluorometilo, alcoxi (C1-C3) y trifluorometoxi.
ES99931266T 1998-08-03 1999-07-23 Imidazo(1,2a)azinas sustituidas como inhibidores selectivos de la cox-2. Expired - Lifetime ES2182546T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801652A ES2140354B1 (es) 1998-08-03 1998-08-03 Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2.
PCT/ES1999/000235 WO2000008024A1 (es) 1998-08-03 1999-07-23 IMIDAZO[1,2a]AZINAS SUSTITUIDAS COMO INHIBIDORES SELECTIVOS DE LA COX-2

Publications (1)

Publication Number Publication Date
ES2182546T3 true ES2182546T3 (es) 2003-03-01

Family

ID=8304755

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009801652A Expired - Lifetime ES2140354B1 (es) 1998-08-03 1998-08-03 Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2.
ES99931266T Expired - Lifetime ES2182546T3 (es) 1998-08-03 1999-07-23 Imidazo(1,2a)azinas sustituidas como inhibidores selectivos de la cox-2.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES009801652A Expired - Lifetime ES2140354B1 (es) 1998-08-03 1998-08-03 Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2.

Country Status (30)

Country Link
US (1) US6670365B1 (es)
EP (1) EP1104762B1 (es)
JP (1) JP2002522438A (es)
KR (1) KR20010079602A (es)
CN (1) CN1131865C (es)
AP (1) AP2001002082A0 (es)
AT (1) ATE224391T1 (es)
AU (1) AU749770B2 (es)
BG (1) BG105299A (es)
BR (1) BR9912968A (es)
CA (1) CA2339187A1 (es)
CZ (1) CZ291783B6 (es)
DE (1) DE69903046T2 (es)
DK (1) DK1104762T3 (es)
EA (1) EA003399B1 (es)
ES (2) ES2140354B1 (es)
HU (1) HUP0103004A3 (es)
ID (1) ID28539A (es)
IL (1) IL141242A0 (es)
MX (1) MXPA01001332A (es)
NO (1) NO20010568L (es)
NZ (1) NZ510196A (es)
OA (1) OA11592A (es)
PL (1) PL345804A1 (es)
PT (1) PT1104762E (es)
SK (1) SK1662001A3 (es)
TR (1) TR200100359T2 (es)
WO (1) WO2000008024A1 (es)
YU (1) YU7401A (es)
ZA (1) ZA200101632B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100793668B1 (ko) 1999-12-08 2008-01-10 파마시아 코포레이션 강화된 생체이용률을 지닌 고체상 형태의 셀레콕시브
US8241622B2 (en) * 2001-07-13 2012-08-14 University Of Iowa Research Foundation Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
DE10247271A1 (de) * 2002-10-10 2004-08-26 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yle
DE10256881A1 (de) * 2002-12-05 2004-06-24 Beiersdorf Ag Neue topische Verwendung von Bis-Arylimidazo[1,2-a]thiolanderivaten
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
ES2298798T3 (es) * 2003-07-30 2008-05-16 Laboratorios S.A.L.V.A.T., S.A. Imidazopirimidinas sustituidas para la prevencion y el tratamiento del cancer.
WO2007034278A2 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Fused imidazole derivatives as c3a receptor antagonists
CA2634670A1 (en) * 2005-12-30 2007-07-12 University Of Iowa Research Foundation Method of identifying compounds useful to treat neuronal degenerative diseases
WO2007096764A2 (en) * 2006-02-27 2007-08-30 Glenmark Pharmaceuticals S.A. Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
CN101861316B (zh) * 2007-11-14 2013-08-21 奥梅-杨森制药有限公司 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
AU2009300318A1 (en) * 2008-10-01 2010-04-08 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses
GB201321732D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2017139381A1 (en) 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
CA3016985C (en) 2016-03-07 2023-07-04 University Of Iowa Research Foundation Aav-mediated expression using a synthetic promoter and enhancer
WO2017205739A1 (en) 2016-05-26 2017-11-30 University Of Iowa Research Foundation cis AND trans REQUIREMENTS FOR TERMINAL RESOLUTION OF HUMAN BOCAVIRUS 1
US11142775B2 (en) 2017-01-13 2021-10-12 University Of Iowa Research Foundation Bocaparvovirus small noncoding RNA and uses thereof
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785133A (en) * 1954-03-26 1957-03-12 Gen Aniline & Film Corp Compositions for a method of whitening fine fabrics
US3455924A (en) * 1967-02-08 1969-07-15 Upjohn Co Dianisylimidazoles
AU9137591A (en) 1990-12-13 1992-07-08 Smithkline Beecham Corporation Novel csaids
WO1993019066A1 (fr) * 1992-03-17 1993-09-30 Nippon Shinyaku Co., Ltd. Derive de l'imidazopyridine et medicament
US5620999A (en) * 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
CN1186492A (zh) * 1995-04-04 1998-07-01 葛兰素集团有限公司 咪唑并[1,2-α]吡啶衍生物
UA57002C2 (uk) * 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування

Also Published As

Publication number Publication date
MXPA01001332A (es) 2002-11-29
PL345804A1 (en) 2002-01-02
PT1104762E (pt) 2002-11-29
IL141242A0 (en) 2002-03-10
BG105299A (en) 2001-11-30
ZA200101632B (en) 2001-08-30
US6670365B1 (en) 2003-12-30
SK1662001A3 (en) 2001-08-06
DK1104762T3 (da) 2002-10-21
BR9912968A (pt) 2001-05-08
ES2140354A1 (es) 2000-02-16
CN1321157A (zh) 2001-11-07
EA003399B1 (ru) 2003-04-24
CA2339187A1 (en) 2000-02-17
NZ510196A (en) 2002-09-27
DE69903046D1 (de) 2002-10-24
HK1037629A1 (en) 2002-02-15
WO2000008024A1 (es) 2000-02-17
ID28539A (id) 2001-05-31
OA11592A (en) 2004-07-30
EP1104762B1 (en) 2002-09-18
DE69903046T2 (de) 2003-05-22
HUP0103004A3 (en) 2003-03-28
YU7401A (sh) 2003-10-31
CN1131865C (zh) 2003-12-24
EP1104762A1 (en) 2001-06-06
NO20010568D0 (no) 2001-02-02
CZ2001433A3 (cs) 2001-08-15
ATE224391T1 (de) 2002-10-15
ES2140354B1 (es) 2000-11-01
NO20010568L (no) 2001-04-02
EA200100212A1 (ru) 2001-08-27
AP2001002082A0 (en) 2001-03-31
JP2002522438A (ja) 2002-07-23
KR20010079602A (ko) 2001-08-22
TR200100359T2 (tr) 2001-06-21
AU4782499A (en) 2000-02-28
CZ291783B6 (cs) 2003-05-14
HUP0103004A2 (hu) 2002-01-28
AU749770B2 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
ES2182546T3 (es) Imidazo(1,2a)azinas sustituidas como inhibidores selectivos de la cox-2.
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
ES2193990T3 (es) Derivados de purina.
AR006390A1 (es) Derivados de lactama
PT1140851E (pt) 4-oxo-1,4-di-hidro-3-quinolinacarboxamidas como agentes antivirais
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
GB9801690D0 (en) Therapeutic agents
CO5180557A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonan-4-carboxilatos y carboxamidas y sus composiciones farmaceuticas .
LV12712A (lv) Inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodekstrin and method
ATE302775T1 (de) Carbolinderivate
MY125359A (en) Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods.
FI883669A0 (fi) 1-/(4-piperidinyl) metyl/ -1,2,3,4-tetrahydro-9h-pyrido/3.4-b/ indolderivat, deras framstaellning och terapeutiska anvaendning.
MEP24208A (en) Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
DE60318826D1 (de) Alkoxypyridinderivate
DE60005689D1 (de) Neue aminobenzophenone
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
NO894563L (no) Substituerte imidazolderivater og fremstilling og anvendelse derav.
ATE259813T1 (de) Triazolopyrimidinderivate
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
NZ336091A (en) Aqueous disinfecting cleaning composition
BR0108845A (pt) 4-hidroxi-1,8-naftiridina-3-carboxamidas como agentes antivirais
CO4940417A1 (es) DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
DE60017374D1 (de) Antibakterielle mittel
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.
AR027035A1 (es) Pirroles sustituidos